These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23648663)

  • 1. In vivo activity of ursolic and oleanolic acids during the acute phase of Trypanosoma cruzi infection.
    da Silva Ferreira D; Esperandim VR; Toldo MP; Kuehn CC; do Prado Júnior JC; Cunha WR; e Silva ML; de Albuquerque S
    Exp Parasitol; 2013 Aug; 134(4):455-9. PubMed ID: 23648663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Anti-Trypanosoma cruzi activity of posaconazole in a murine model of acute Chagas' disease is less dependent on gamma interferon than that of benznidazole.
    Ferraz ML; Gazzinelli RT; Alves RO; Urbina JA; Romanha AJ
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1359-64. PubMed ID: 17220408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro trypanocidal activity of triterpenes from miconia species.
    Cunha WR; Martins C; da Silva Ferreira D; Crotti AE; Lopes NP; Albuquerque S
    Planta Med; 2003 May; 69(5):470-2. PubMed ID: 12802734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dehydroepiandrosterone-sulfate (DHEA-S) and benznidazole treatments during acute infection of two different Trypanosoma cruzi strains.
    Santos CD; Loria RM; Oliveira LG; Kuehn CC; Toldo MP; Albuquerque S; do Prado JC
    Immunobiology; 2010 Dec; 215(12):980-6. PubMed ID: 20163889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in vitro iron superoxide dismutase inhibitor decreases the parasitemia levels of Trypanosoma cruzi in BALB/c mouse model during acute phase.
    Olmo F; Urbanová K; Rosales MJ; Martín-Escolano R; Sánchez-Moreno M; Marín C
    Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):110-6. PubMed ID: 26236582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursolic acid and oleanolic acid suppress preneoplastic lesions induced by 1,2-dimethylhydrazine in rat colon.
    Furtado RA; Rodrigues EP; Araújo FR; Oliveira WL; Furtado MA; Castro MB; Cunha WR; Tavares DC
    Toxicol Pathol; 2008 Jun; 36(4):576-80. PubMed ID: 18467683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vivo trypanocidal effect of the diterpene 5-epi-icetexone obtained from Salvia gilliesii.
    Lozano E; Strauss M; Spina R; Cifuente D; Tonn C; Rivarola HW; Sosa MA
    Parasitol Int; 2016 Feb; 65(1):23-26. PubMed ID: 26341064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
    Fernández MC; González Cappa SM; Solana ME
    Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanocidal activity and acute toxicity assessment of triterpene acids.
    Ferreira Dda S; Esperandim VR; Toldo MP; Saraiva J; Cunha WR; de Albuquerque S
    Parasitol Res; 2010 Mar; 106(4):985-9. PubMed ID: 20140451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanosoma cruzi: in vitro and in vivo antiproliferative effects of epigallocatechin gallate (EGCg).
    Güida MC; Esteva MI; Camino A; Flawiá MM; Torres HN; Paveto C
    Exp Parasitol; 2007 Oct; 117(2):188-94. PubMed ID: 17673202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benznidazole alters the pattern of Cyclophosphamide-induced reactivation in experimental Trypanosoma cruzi-dependent lineage infection.
    Santos DM; Martins TA; Caldas IS; Diniz LF; Machado-Coelho GL; Carneiro CM; Oliveira Rde P; Talvani A; Lana M; Bahia MT
    Acta Trop; 2010 Feb; 113(2):134-8. PubMed ID: 19854145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of immunosuppression and benzonidazole on Trypanosoma cruzi parasitism during experimental acute Chagas' disease.
    Okumura M; Mester M; Iriya K; Amato Neto V; Gama-Rodrigues J
    Transplant Proc; 1994 Jun; 26(3):1587-9. PubMed ID: 8030049
    [No Abstract]   [Full Text] [Related]  

  • 14. Trypanosoma cruzi: alteration in the lymphoid compartments following interruption of infection by early acute benznidazole therapy in mice.
    Olivieri BP; de Souza AP; Cotta-de-Almeida V; de Castro SL; Araújo-Jorge T
    Exp Parasitol; 2006 Nov; 114(3):228-34. PubMed ID: 16620811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosoma cruzi: effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice.
    Francisco AF; de Abreu Vieira PM; Arantes JM; Pedrosa ML; Martins HR; Silva M; Veloso VM; de Lana M; Bahia MT; Tafuri WL; Carneiro CM
    Exp Parasitol; 2008 Dec; 120(4):314-9. PubMed ID: 18789321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Trypanosoma cruzi high parasitemia in patient with systemic lupus erythematosus].
    dos Santos-Neto LL; Polcheira MF; Castro C; Lima RA; Simaan CK; Corrêa-Lima FA
    Rev Soc Bras Med Trop; 2003; 36(5):613-5. PubMed ID: 14576877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.
    Abrahamsohn IA; Coffman RL
    Exp Parasitol; 1996 Nov; 84(2):231-44. PubMed ID: 8932773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.
    Dos Santos FM; Caldas S; de Assis Cáu SB; Crepalde GP; de Lana M; Machado-Coelho GL; Veloso VM; Bahia MT
    Exp Parasitol; 2008 Dec; 120(4):385-90. PubMed ID: 18823980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimutagenicity of ursolic acid and oleanolic acid against doxorubicin-induced clastogenesis in Balb/c mice.
    Aparecida Resende F; de Andrade Barcala CA; da Silva Faria MC; Kato FH; Cunha WR; Tavares DC
    Life Sci; 2006 Aug; 79(13):1268-73. PubMed ID: 16647723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice.
    Torrico F; Heremans H; Rivera MT; Van Marck E; Billiau A; Carlier Y
    J Immunol; 1991 May; 146(10):3626-32. PubMed ID: 1902858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.